Growth is driven by rising COPD cases due to smoking and pollution, and enhanced therapeutic options like bronchodilators and biologics. Significant investments are improving diagnosis and treatment.

The CT-based whole-lung radiomic nomogram accurately identifies AECOPD and offers a robust tool for clinical diagnosis and treatment planning.

Temple Health leads research showing how women and non-smokers face rising risks, and how new treatments are changing the ...

Melbourne-based RAGE Biotech has raised $29 million in Series A to take its treatment for chronic lung disease into ...

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...

Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study ...

Chronic obstructive pulmonary disease is a condition caused by damage to the lungs that results in breathing difficulties.

Adults hospitalized for acute COPD exacerbation faced elevated odds for all-cause mortality and ICU admission if they had end-stage renal disease and were on dialysis, according to data presented at ...

Chronic Obstructive Pulmonary Disease, or COPD, is a progressive lung condition that affects millions of people in the United ...

Researchers have identified in a new study that patients suffering from chronic obstructive pulmonary disease (COPD) who ...

The COPD Action Alliance applauds Governor Bill Lee for proclaiming November as Chronic Obstructive Pulmonary Disease (COPD) Awareness Month in Tennessee, recognizing the urgent need for greater ...